Nanostart-holding MagForce Nanotechnologies Announces Capital Increase from Authorized Capital  
2/1/2012 6:07:22 AM

FRANKFURT, Germany & BERLIN--(BUSINESS WIRE)--The Management Board of Nanostart (OTCQX:NASRY) - holding MagForce AG (XETRA:MF6), a leading medical technology company focusing on nanomedicine in oncology, and its Supervisory Board yesterday approved an increase in the company’s share capital from EUR 4,127,041.00 up to EUR 4,952,449.00 through the partial utilization of its existing authorized capital of up to EUR 825,408.00 newly registered common shares with no par value common with a nominal value of EUR 1.00 per share against cash contributions.